Loading…
Reported covered position: Rep. Bob Gibbs - Legislative Aide
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Student Loan Tax Elimination Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Issues related to FY2026 Appropriations
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Student Loan Tax Elimination Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Student Loan Tax Elimination Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Student Loan Tax Elimination Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666) Issues Related to Tax and Trade
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666) Issues Related to Tax and Trade
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666) Issues Related to Tax and Trade
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666) Issues Related to Tax and Trade
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Farm, Food, and National Security Act of 2024
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
National Defense Authorization Act for Fiscal Year 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
National Defense Authorization Act H.R. 4350 and S.2792 National Defense Authorization Act for Fiscal year 2022
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, H.R. 4356 and H.R. 4502 Agriculture, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, H.R. 4356 and H.R. 4502 Agriculture, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to FY 2022 Appropriations S. 2599, H.R. 4356 and H.R. 4502 Agriculture, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
National Defense Authorization Act for Fiscal Year 2022
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
National Defense Authorization Act H.R. 4350 and S.2792 National Defense Authorization Act for Fiscal year 2022
Further Extension of Continuing Appropriations Act, 2021
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Prescription Drug STAR Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
More Efficient Tools to Realize Information for Consumers Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Elijah E. Cummings Lower Drug Costs Now Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
America Stands with Israel Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to counterfeit products - H.R. 4156 Issues related to rural broadband Health Dog Importation Act
America Stands with Israel Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to counterfeit products - H.R. 4156 Issues related to rural broadband Issues related to foreign animal disease - H.R. 6921
Protecting America's Food and Agriculture Act of 2019
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding H.R. 6921 Healthy Dog Importation Act China Phase 1 and Policy Related Issues
Protecting America's Food and Agriculture Act of 2019
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding
ACCESS for Biosimilars Act of 2019
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Biosimilars S. 3466/H.R. 4597, and H.R. 6179/S. 4134
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Increasing Access to Biosimilars Act of 2020
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Biosimilars S. 3466/H.R. 4597, and H.R. 6179/S. 4134
Families First Coronavirus Response Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Healthy Dog Importation Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to counterfeit products - H.R. 4156 Issues related to rural broadband Issues related to foreign animal disease - H.R. 6921
Healthy Dog Importation Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding H.R. 6921 Healthy Dog Importation Act China Phase 1 and Policy Related Issues
CARES Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
CREATES Act of 2019
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Ensuring Timely Access to Generics Act of 2019
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Lower Health Care Costs Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2020
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Biosimilars S. 3466/H.R. 4597, and H.R. 6179/S. 4134
Strengthening America’s Supply Chain and National Security Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
Increasing Access to Biosimilars Act of 2020
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Biosimilars S. 3466/H.R. 4597, and H.R. 6179/S. 4134
Protecting America's Food and Agriculture Act of 2019
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding CVP Topic of Appropriations
Agriculture Improvement Act of 2018
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate - Agriculture Improvement Act of 2018 (S. 3042) House - Agriculture and Nutrition Act of 2018 (H.R. 2)
Agriculture Improvement Act of 2018
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate = Agriculture Improvement Act of 2018 (S.3042) House = Agriculture and Nutrition Act of 2018 (H.R. 2)
Agriculture Improvement Act of 2018
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate = Agriculture Improvement Act of 2018 (S.3042) House = Agriculture and Nutrition Act of 2018 (H.R. 2)
Agriculture Improvement Act of 2018
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate - Agriculture Improvement Act of 2018 (S. 3042) House - Agriculture and Nutrition Act of 2018 (H.R. 2)
Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2026 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Issues related to FY2026 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Issues related to the regulatory process Issues related to transboundary animal disease control and prevention Issues related to avian influenza Issues related to New World Screwworm Issues Related to Tax and Trade
Issues related to FY2026 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to PAW Act (H.R. 1842) Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666) Issues Related to Tax and Trade
Issues related to FY2026 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2026 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2026 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY2024 Appropriations
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2024 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Farm, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2024 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY2024 Appropriations
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY2024 Appropriations
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2024 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
Issues related to FY2024 Appropriations
Issues related to National Defense Authorization Act
Prescription drug manufacturing and supply chains
Issues related to National Defense Authorization Act
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418)
Prescription drug manufacturing and supply chains
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418)
Issues related to National Defense Authorization Act
Issues Related to National Defense Authorization Act
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health Issues related to Pesticide Registration Improvement Act and issues related to compounding
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health
Issues Related to National Defense Authorization Act
Prescription drug manufacturing and supply chains
Issues Related to National Defense Authorization Act
Prescription drug manufacturing and supply chains
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Issues Related to National Defense Authorization Act
Prescription drug manufacturing and supply chains
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health
Issues related to FY 2022 Appropriations S. 2599, H.R. 4356 and H.R. 4502 Agriculture, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
National Defense Authorization Act H.R. 4350 and S.2792 National Defense Authorization Act for Fiscal year 2022
Issues related to National Defense Authorization Act Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health
Prescription drug manufacturing and supply chains
Issues related to FY 2022 Appropriations
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to rural broadband Issues related to One Health
Prescription drug manufacturing and supply chains
Issues related to FY 2022 Appropriations
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Prescription drug manufacturing and supply chains
Issues related to FY 2022 Appropriations
Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to rural broadband Issues related to One Health
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Biosimilars S. 3466/H.R. 4597, and H.R. 6179/S. 4134
Prescription drug manufacturing and supply chains
Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to counterfeit products - H.R. 4156 Issues related to rural broadband Health Dog Importation Act
Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533 Issues related to veterinary telehealth Issues related to counterfeit products - H.R. 4156 Issues related to rural broadband Issues related to foreign animal disease - H.R. 6921
Prescription drug manufacturing and supply chains
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues
Diabetes and Heart Health Awareness S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Cut of 2019 H.R. 748 CARES Act H.R. 6201 Families First Coronavirus Response Act H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 S. 3538, the Strengthening Americas Supply Chain and National Security Act (Sen. Rubios bill) Issues Related to Fiscal Year 2021 Appropriations for the Labor, Health and Human Services, and Education Agencies
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding
Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
Pesticide Registration Improvement Act (PRIA) Farm Bill Implementation
Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding CVP Topic of Appropriations
Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Pesticide Registration Improvement Act (PRIA) Farm Bill Implementation
Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Pesticide Registration Improvement Act (PRIA) Farm Bill Implementation
Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Trade Agreements including NAFTA, USMCA, and related policy issues Intellectual Property and Market Access Policy Issues
Pesticide Registration Improvement Act (PRIA) Farm Bill Implementation
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, U.S. Trade & Development Agency (USTDA)
Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate - Agriculture Improvement Act of 2018 (S. 3042) House - Agriculture and Nutrition Act of 2018 (H.R. 2)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate = Agriculture Improvement Act of 2018 (S.3042) House = Agriculture and Nutrition Act of 2018 (H.R. 2)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Prescription drug manufacturing and supply chains
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY2024 Appropriations
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY2024 Appropriations
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Prescription drug manufacturing and supply chains
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Prescription drug manufacturing and supply chains
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
HR. 4482 General Foreign Animal Disease Center for Veterinary Biologics Funding Farm Bill Implementation Agriculture Inspector Funding H.R. 6921 Healthy Dog Importation Act China Phase 1 and Policy Related Issues
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE